'Fast track' refers to the approval process! ..... not taking short cuts in the preclinical, phase 1, 2 & 3, manufacturing and quality control steps. Phase 1 & 2 can easily be done here quite quickly and by the time Phase 3 is rolled out....possibly early next year, I think there will be 35% or more of the Australian population still unvaccinated....so still plenty of candidates to be available. AstraZeneca's main trial was completed (primary completion) in just over 6 months with a patient enrollment of approximately 32,000. The Australian study could be set up in a couple of centres in capital cities with of course an 'incentive' payment for each patient for their "inconvenience" each visit. Will cost probably $ 25m plus to conduct the trials, but if the phase 2 trials have good results money won't be hard to find.
- Forums
- ASX - By Stock
- IDT
- Ann: COVID-19 Vaccine Manufacture discussions with VicGov & MIPS
Ann: COVID-19 Vaccine Manufacture discussions with VicGov & MIPS, page-51
-
- There are more pages in this discussion • 34 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IDT (ASX) to my watchlist
|
|||||
Last
11.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $38.66M |
Open | High | Low | Value | Volume |
11.0¢ | 11.0¢ | 10.5¢ | $11.44K | 104.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 519 | 11.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
11.5¢ | 149865 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 519 | 0.110 |
3 | 248400 | 0.105 |
4 | 1062473 | 0.100 |
1 | 15000 | 0.098 |
2 | 15500 | 0.096 |
Price($) | Vol. | No. |
---|---|---|
0.115 | 139865 | 2 |
0.120 | 106155 | 4 |
0.125 | 174981 | 2 |
0.130 | 101000 | 3 |
0.135 | 140000 | 2 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
IDT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online